Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pituitary adenylyl cyclase-activating polypeptide (PACAP) receptor type 1 (
PAC
(1)) signaling and desensitization were investigated in human retinoblastoma Y-79 cells. Concentration-dependent stimulation of cAMP accumulation was observed in Y-79 cells incubated for 30 min with PACAP38, PACAP27, or VIP (10(-12) to 10(-6) M). The following EC(50) values were calculated: PACAP38, 24+/-3 pM; PACAP27, 99+/-8 pM; and VIP, 29+/-3 nM. Homologous desensitization of
PAC
(1) receptors in Y-79 cells pretreated with 10 nM PACAP38 or PACAP27 for 60 min was characterized by a 30-50% reduction in PACAP-stimulated cAMP accumulation (p<0.0001) and a two- to fivefold rightward shift in EC(50) values (p<0.0001).
PAC
(1) receptor desensitization was not accompanied by a reduction in
PAC
(1) mRNA expression. We concluded that the desensitizing effect of PACAP38 was homologous because neither corticotropin-releasing factor- nor (-)-isoproterenol-stimulated cAMP accumulation was altered by PACAP38 preincubation. Pretreating Y-79 cells with the protein kinase A (PKA) inhibitor H89 failed to inhibit homologous
PAC
(1) receptor desensitization. Similarly, pretreating Y-79 cells with the protein kinase C (PKC) inhibitors staurosporine or bisindolylmaleimide failed to alter homologous
PAC
(1) receptor desensitization. Although activation of PKA by dibutyryl cAMP or forskolin did not desensitize
PAC
(1) receptors, direct activation of PKC by PMA heterologously desensitized
PAC
(1) receptors, reducing cAMP accumulation 34.2+/-2.2% (p<0.001). Using RT-PCR, mRNA levels for
G-protein-coupled receptor kinase 3
(
GRK3
), but not GRK2, were found to increase 2.2- to 4.8-fold in Y-79 cells exposed to PACAP38 for 10 min to 24 h (p<0.001).
PAC
(1) receptor desensitization decreased 72.5+/-4.3% (p<0.001) in Y-79 cells transfected with a
GRK3
antisense cDNA construct that also reduced
GRK3
protein expression 48.5+/-7.9% (p<0.0005). These experiments demonstrate that
GRK3
plays an important role in the homologous desensitization of retinoblastoma
PAC
(1) receptors, whereas PKC, but not PKA, contributes to the heterologous desensitization of retinoblastoma
PAC
(1) receptors.
...
PMID:G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. 1116 32